Business
Jaguar Health Engages B2i Digital to Deploy Cutting-Edge Investor Engagement Campaign
Jaguar aims to leverage digital technologies including AI enhancement to help connect with investor communitiesSAN FRANCISCO, CA / ACCESSWIRE / August 24,
About this update from Jaguar Health, Inc.
[{"type":"text","content":"Jaguar aims to leverage digital technologies including AI enhancement to help connect with investor communitiesSAN FRANCISCO, CA / ACCESSWIRE / August 24, 2023 / Jaguar Health, Inc. (NASDAQ:JAGX), a commercial-stage pharmaceuticals company developing first-in-class plant-based gastrointestinal (GI) prescription medicines, today announced it has engaged B2i Digital to execute an innovative digital investor engagement and awareness program. B2i will harness its investor platform and data-driven digital marketing expertise to highlight Jaguar's novel pipeline of prescription drugs sustainably derived from rainforest plants.\"With major late-stage clinical catalysts approaching, we want to ensure our story reaches new audiences in the investment community,\" said Jaguar founder and CEO Lisa Conte. \"B2i Digital's cutting-edge technologies will allow us to communicate our progress, competitive advantages, and long-term vision to stakeholders.\"\"We are thrilled to partner with Jaguar as they pioneer novel plant-based prescription drugs that could transform how we treat GI diseases,\" said David Shapiro, B2i Digital CEO. \"Once we evaluated Jaguar's promising pipeline assets like crofelemer for cancer therapy-related diarrhea and rare disorders, we realized our digital investor engagement platform is ideal for expanding their investor base and visibility within the financial markets. These digital efforts will be combined with traditional corporate access activities such as investor conferences, fireside chats, and Non-Deal Roadshows (NDRs).\"\"From Mytesi® for HIV-related diarrhea to the Canalevia®-CA1 FDA conditional approval in dogs, Jaguar is delivering on its mission to develop sustainably sourced GI prescription medicines that improve patient lives,\" Shapiro added. \"We will leverage the full power of our digital toolset to showcase Jaguar's unique leadership position in the emerging field of novel pharmaceuticals approved under FDA Botanical Guidance to our 410,000+ social media community of investors.\"About B2i Digital, Inc.B2i Digital, Inc. leverages the latest digital marketing technologies to tell a company's story to retail investors, institutional investors, and research analysts. B2i Digital creates robust profiles for companies on its platform, b2idigital.com, and launches targeted digital marketing campaigns to bring...